Marie-Cécile Parrens

9PUBLICATIONS
194CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 04, 2025
Brentuximab vedotin addition to gemcitabine in relapsed or refractory peripheral T-cell lymphoma: a LYSA phase 2 study.

Olivier Tournilhac, Kamal Bouabdallah, Solène Lecolant

|May 01, 2025
TRANSCAR: real-world outcomes of CD19 CAR T-cell therapy in relapsed/refractory transformed indolent lymphomas.

Pierre Stephan, Roberta Di Blasi, Louise Roulin

|Feb 26, 2025
Characterization and treatment outcomes of malignant histiocytoses in a retrospective series of 141 cases in France.

Camille Bigenwald, Damien Roos-Weil, Arnaud Pagès

|Jan 28, 2025
Outcome of high-grade B-cell lymphoma compared with other large B-cell lymphoma after CAR-T rescue: a DESCAR-T LYSA study.

Xavier Phina-Ziebin, Emmanuel Bachy, François-Xavier Gros

|Apr 24, 2024
Comprehensive Genetic Profiling Reveals Frequent Alterations of Driver Genes on the X Chromosome in Extranodal NK/T-cell Lymphoma.

Yuta Ito, Amira Marouf, Yasunori Kogure

|Apr 04, 2023
The Negative Influence of Baseline Cell-free DNA on Long-term Survival in DLBCL Depends on Frontline Treatment Intensity.

Fabienne Desmots, Delphine Rossille, Mikael Roussel

Pageof 2

Frequent Collaborators

5 joint publications

Gandhi Laurent Damaj

4 joint publications

Emmanuel Bachy

3 joint publications

Steven Le Gouill

3 joint publications

Olivier Tournilhac